Silicon Valley startup targets barriers to cancer screenings; New data on stool-based colorectal cancer screening test

Exact Sciences is touting accuracy of its updated Cologuard cancer test, but experts want more data.

June 23, 2023 Check out STAT+

Sponsored By

Celebrate an early-career researcher by nominating them for STAT Wunderkinds. Applications are still open for our 2023 honorees.

Color Health STAT+ | Using its Covid know-how, Color Health aims to make cancer screenings convenient The tech company, known for its Covid-19 testing, is trying to remove "all your excuses" to getting to recommended screenings. By Angus Chen STAT+ | Exact Sciences touts accuracy of updated Cologuard cancer test, but experts want more data While the biotech plans to use the data to apply for regulatory approval, cancer specialists say they need to see more details. By Jonathan Wosen New DNA test aims to make cervical cancer screening more accessible in low-income countries A new study suggests an HPV DNA test could make cervical cancer screening more accessible to women in developing countries. By Abdullahi Tsanni Graeme Sloan/Sipa USA STAT+ | PhRMA sues Biden administration over Medicare drug price negotiation program The pharmaceutical industry's biggest lobbying group filed a lawsuit challenging Democrats' Medicare drug pricing law. By Rachel Cohrs

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser